Tamoxifen has also been used off label for malignant glioma (type of nervous system tumor), ovarian cancer, mastalgia (breast pain), infertility, osteoporosis, and precocious puberty.AnswerPalliative or adjunctive treatment of advanced breast cancer; reduce the incidence of breast cancer in women at high risk; reduce risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS); metastatic male breast cancer; treatment of melanoma, desmoid tumors
They can do charities just for them
There is no evidence that HPV causes ovarian cancer.
Clinical Ovarian Cancer was created in 2008.
Studies show that a vegan diet can help reduce the risk of ovarian cancer. Click on the link below, under 'Related links'.
There are many alternative treatments available to help with ovarian cancer. Alternative treatments can be used in conjunction with, or separate from, surgery, chemotherapy, and radiation therapy.
Wisconsin Ovarian Cancer Alliance was created in 2001.
Yes, ovarian cancer is sometimes referred to as ovarian carcinoma, which specifically denotes cancer that originates in the ovarian tissue. It can also be classified based on the type of cells involved, such as epithelial, germ cell, or stromal tumors, but "ovarian cancer" is the most commonly used term.
A pap smear will not detect ovarian cancer. Ovarian cancer won't affect whether a pap smear is normal or abnormal -- it could be either one.
Overall, ovarian cancer accounts for only 4% of all cancers in women
None. You cannot treat ovarian cancer with diet supplements.
Tamoxifen, a medication commonly used to treat and prevent breast cancer, has both benefits and potential risks. It works as a selective estrogen receptor modulator (SERM) by blocking estrogen receptors on breast cancer cells, thereby inhibiting the growth of estrogen-dependent tumors. However, it also has some associated risks, including an increased risk for certain types of cancer. Potential Risks Associated with Tamoxifen Endometrial Cancer: Increased Risk: Tamoxifen has been linked to an increased risk of endometrial cancer (cancer of the lining of the uterus). The risk is higher for women who take Tamoxifen for extended periods. Mechanism: While Tamoxifen acts as an estrogen antagonist in breast tissue, it can act as an estrogen agonist in the endometrium, promoting cell growth and potentially leading to cancer. Uterine Sarcoma: Rare but Serious: Tamoxifen use is also associated with a rare but serious risk of uterine sarcoma, a type of cancer that occurs in the muscle and supporting tissues of the uterus. Other Considerations: Thromboembolic Events: Tamoxifen increases the risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Stroke: There is a slightly increased risk of stroke in women taking Tamoxifen. Weighing the Risks and Benefits Benefits: Breast Cancer Treatment: Tamoxifen is highly effective in reducing the risk of breast cancer recurrence in premenopausal and postmenopausal women. Breast Cancer Prevention: For women at high risk of developing breast cancer, Tamoxifen can significantly reduce the likelihood of the disease. Risk Management: Regular Monitoring: Women taking Tamoxifen should have regular gynecological exams to monitor for signs of endometrial cancer. Individualized Decision: The decision to use Tamoxifen should be based on a thorough discussion with a healthcare provider, considering the individual's risk factors, benefits, and potential side effects. Conclusion While Tamoxifen can increase the risk of certain cancers, particularly endometrial cancer and uterine sarcoma, its benefits in treating and preventing breast cancer often outweigh these risks for many women. It's crucial to have regular medical check-ups and discuss any concerns with a healthcare provider to ensure that the benefits of Tamoxifen use continue to outweigh the potential risks.